Thermo Fisher Partners with HealthVerity to Boost Real-World Data in Clinical Research

Thermo Fisher Scientific, a leader in science services, has teamed up with HealthVerity to enhance its real-world data capabilities in clinical research. This strategic partnership will grant Thermo Fisher’s PPD clinical research division enterprise-level access to HealthVerity’s extensive TaXOnomy® claims dataset, covering over 270 million de-identified patient records across the U.S. This collaboration promises to enhance data-driven insights into disease trends and treatment patterns, significantly impacting biopharmaceutical research.

Thermo Fisher’s agreement with HealthVerity represents an important development in integrating extensive real-world data into clinical research. In addition to claims data, the partnership provides access to 70 curated data sources, including electronic medical records and lab results, strengthening the efficiency and accuracy of clinical trials. This data accessibility coupled with Thermo Fisher’s advanced AI analytics will facilitate refined site selection and faster trial initiations. This marks a significant step towards more informed and effective research design, promising to enhance outcomes for biopharma sponsors.

With this collaboration, Thermo Fisher continues its investment in digital innovations, enhancing its capability to deliver valuable insights across the clinical research continuum. By tapping into HealthVerity’s integrated data ecosystem, Thermo Fisher is poised to advance its real-world evidence generation, ultimately improving patient outcomes and driving smarter clinical development. This initiative is a testament to Thermo Fisher’s commitment to pioneering advancements in life sciences research.